Rating History for Gyre Therapeutics (GYRE) by H.C. Wainwright

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/2/2026 Matthew Keller Maintain Buy
(N/A)
18.00
(N/A)
 
 
  Details